Standout Papers

<scp>LAG</scp>3 (<scp>CD</scp>223) as a cancer immunotherapy target 2017 2026 2020 2023 658
  1. LAG3 (CD223) as a cancer immunotherapy target (2017)
    Lawrence P. Andrews, Ariel E. Marciscano et al. Immunological Reviews

Immediate Impact

2 by Nobel laureates 18 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Natural killer cell therapies
2024 StandoutNature
4 intermediate papers

Works of Ariel E. Marciscano being referenced

The role of dendritic cells in cancer and anti-tumor immunity
2021
LAG3 (CD223) as a cancer immunotherapy target
2017 Standout

Author Peers

Author Last Decade Papers Cites
Ariel E. Marciscano 1219 541 788 51 2.0k
Kent C. Shih 1653 496 408 54 2.5k
Jacques Bosq 1135 278 613 73 2.5k
K Aozasa 1498 477 481 71 2.8k
Eva Geissinger 849 330 636 78 2.2k
Michel Symann 1247 254 424 95 2.2k
Monica Loghin 1664 679 439 44 2.6k
Said Jw 1133 334 358 34 1.9k
Daniel Molin 1490 213 900 75 2.4k
Martin L. Hansmann 1029 217 410 72 2.2k
Konnie M. Hebeda 866 257 358 91 2.4k

All Works

Loading papers...

Rankless by CCL
2026